Global Medical Director, Sleep Disorders - Neurology Global Medical Affairs

Responsibilities

• Global Medical Strategy
• Drive alignment with regional medical teams and clinical development team as well as global value & access team
• Create global scientific narratives
• Develop lifecycle management strategies (including RWE, publications)
• Address unmet needs and optimize launch performance
• Provide direction on key internal business processes for approved and pipeline assets in the orexin class
• Work with scientific communication team to ensure Global IIS strategies in place and review IIS proposals in conjunction with the policies.
• Pipeline Strategy – (Late Phase Development)
• Provide medical leadership for Phase 2 readout and Phase 3 readiness
• Develop early and evolving scientific narratives to position pipeline compounds within the orexin class and broader sleep landscape
• Contribute to Phase 3 clinical development plans
• Engage in external scientific leadership and KOL engagement
• Identify, map, and develop relationships with global and regional sleep disorder KOLs
• Support internal decision-making through robust scientific interpretation of data
• Monitor and synthesize competitive landscape developments
• Translate insights into strategic recommendations
• Ensure the organization is seen as a credible scientific leader in sleep disorders and orexin biology

Qualifications

• PhD, MD, or PharmD with 5+ years of relevant experience
• Advanced degree in sciences or related field with substantial experience in the pharma/biotech industry
• Experience in Life Sciences industry preferred
• Demonstrated experience in Global medical roles with cross-regional responsibility
• Product launch and lifecycle management experience
• Late-phase development (Phase 2/3 involvement) experience
• Experience in sleep disorders or orexin biology strongly preferred
• Excellent communication and presentation skills
• Proven ability to lead in complex, matrixed, multinational environments with diverse stakeholders
• Deep understanding of the drug development lifecycle, evidence generation, and Medical Affairs governance
• Practical knowledge of FDA regulations/ICH guidelines regarding conduct of clinical studies in relevant therapeutic areas